T regulatory cells and transplantation tolerance.

[1]  Brigitta Stockinger,et al.  The functional plasticity of T cell subsets , 2009, Nature Reviews Immunology.

[2]  L. King,et al.  CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. , 2009, The Journal of clinical investigation.

[3]  P. Boros,et al.  Human FOXP3+ Regulatory T Cells in Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[5]  C. Larsen,et al.  Translating costimulation blockade to the clinic: lessons learned from three pathways , 2009, Immunological reviews.

[6]  Alf Hamann,et al.  Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? , 2009, Nature Reviews Immunology.

[7]  H. Kolb.  Graft-versus-leukemia effects of transplantation and donor lymphocytes. , 2008, Blood.

[8]  Shimon Sakaguchi,et al.  Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation , 2008, Proceedings of the National Academy of Sciences.

[9]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[10]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[11]  P. Janson,et al.  FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans , 2008, PloS one.

[12]  S. Alexopoulos,et al.  Effects of Cyclosporine on Transplant Tolerance: The Role of IL‐2 , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  Wei Yang,et al.  New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses. , 2007, Blood.

[14]  T. Nomura,et al.  Foxp3 and Aire in thymus-generated Treg cells: a link in self-tolerance , 2007, Nature Immunology.

[15]  Shimon Sakaguchi,et al.  Natural regulatory T cells: mechanisms of suppression. , 2007, Trends in molecular medicine.

[16]  Y. Wan,et al.  Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression , 2007, Nature.

[17]  Edgar Schmitt,et al.  Epigenetic Control of the foxp3 Locus in Regulatory T Cells , 2007, PLoS biology.

[18]  Jean Kanitakis,et al.  Isolation of Regulatory T Cells in the Skin of a Human Hand-Allograft, Up to Six Years Posttransplantation , 2006, Transplantation.

[19]  Li Zhang,et al.  Double-Negative T Regulatory Cells Can Develop Outside the Thymus and Do Not Mature from CD8+ T Cell Precursors1 , 2006, The Journal of Immunology.

[20]  L. Walker,et al.  The role of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) in regulatory T‐cell biology , 2006, Immunological reviews.

[21]  E. Shevach,et al.  The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells , 2006, Immunological reviews.

[22]  L. Chess,et al.  Regulation of immune responses by T cells. , 2006, The New England journal of medicine.

[23]  V. Sharma,et al.  Messenger RNA for FOXP3 in the urine of renal-allograft recipients. , 2005, The New England journal of medicine.

[24]  B. Baban,et al.  A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation. , 2005, International immunology.

[25]  M. Karim,et al.  CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation. , 2005, Blood.

[26]  A. Rudensky,et al.  TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.

[27]  A. Rudensky,et al.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.

[28]  Andreas Mackensen,et al.  Isolation and characterization of human antigen-specific TCRαβ+ CD4-CD8- double-negative regulatory T cells , 2005 .

[29]  T. Ley,et al.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death. , 2004, Immunity.

[30]  H. von Boehmer,et al.  In Vivo Instruction of Suppressor Commitment in Naive T Cells , 2004, The Journal of experimental medicine.

[31]  J. Chapman,et al.  The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.

[32]  T. Strom,et al.  The balance of deletion and regulation in allograft tolerance , 2003, Immunological reviews.

[33]  T. Strom,et al.  CD154 on the surface of CD4+CD25+ regulatory t cells contributes to skin transplant tolerance , 2003, Transplantation.

[34]  U. Grohmann,et al.  Modulation of tryptophan catabolism by regulatory T cells , 2003, Nature Immunology.

[35]  V. Kuchroo,et al.  Tim-3 inhibits T helper type 1–mediated auto- and alloimmune responses and promotes immunological tolerance , 2003, Nature Immunology.

[36]  A. Rudensky,et al.  Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation. , 2003, Blood.

[37]  J. Bluestone,et al.  TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes , 2003, Nature Medicine.

[38]  F. Ramsdell,et al.  Foxp3 and natural regulatory T cells: key to a cell lineage? , 2003, Immunity.

[39]  H. Groux.  Type 1 T-regulatory cells: their role in the control of immune responses1 , 2003, Transplantation.

[40]  T. Strom,et al.  Tracking the Immunoregulatory Mechanisms Active During Allograft Tolerance1 , 2002, The Journal of Immunology.

[41]  M. Karim,et al.  CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses1 , 2002, The Journal of Immunology.

[42]  M. Roncarolo,et al.  Type 1 T regulatory cells , 2001, Immunological reviews.

[43]  Hans D. Ochs,et al.  A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome , 2001, Immunogenetics.

[44]  G. Klintmalm,et al.  A randomized double‐blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[45]  T. Strom,et al.  T cell death and transplantation tolerance. , 2001, Immunity.

[46]  F. Powrie,et al.  IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo1 , 2001, The Journal of Immunology.

[47]  E. Palmer,et al.  Quantifying the Frequency of Alloreactive T Cells In Vivo: New Answers to an Old Question1 , 2001, The Journal of Immunology.

[48]  J. Klein,et al.  Adoptively Transferred γδ T Cells Indirectly Regulate Murine Graft-Versus-Host Reactivity Following Donor Leukocyte Infusion Therapy in Mice1 , 2000, The Journal of Immunology.

[49]  Li Zhang,et al.  Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression , 2000, Nature Medicine.

[50]  S. Sakaguchi.  Regulatory T cells , 2006, Springer Seminars in Immunopathology.

[51]  Milton W. Taylor,et al.  Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell Proliferation , 2000, The Journal of Immunology.

[52]  R. Gorczynski,et al.  Evidence for epitope spreading and active suppression in skin graft tolerance after donor-specific transfusion. , 1999, Transplantation.

[53]  D. Munn,et al.  Inhibition of  T Cell Proliferation by Macrophage Tryptophan Catabolism , 1999, The Journal of experimental medicine.

[54]  D. Munn,et al.  Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.

[55]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[56]  D. Balomenos,et al.  The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion. , 1997, Journal of immunology.

[57]  S. Strober,et al.  Double Negative (CD4−CD8−αβ+) T Cells Which Promote Tolerance Induction and Regulate Autoimmunity , 1996, Immunological reviews.

[58]  S. Strober,et al.  Similar rates of production of T and B lymphocytes in the bone marrow , 1995, The Journal of experimental medicine.

[59]  M. Bix,et al.  Positive selection of V beta 8+ CD4-8- thymocytes by class I molecules expressed by hematopoietic cells , 1993, The Journal of experimental medicine.

[60]  R. Budd,et al.  CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor. , 1993, Journal of immunology.

[61]  D. Kioussis,et al.  "Infectious" transplantation tolerance , 1993, Science.

[62]  A. Singer,et al.  Phenotype, ontogeny, and repertoire of CD4-CD8- T cell receptor alpha beta + thymocytes. Variable influence of self-antigens on T cell receptor V beta usage. , 1991, Journal of immunology.

[63]  D. Sachs,et al.  Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen , 1989, The Journal of experimental medicine.

[64]  M. Edelstein,et al.  Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[65]  E. Borden,et al.  Induction of Tryptophan Degradation In Vitro and In Vivo: A γ-Interferon-Stimulated Activity , 1986 .

[66]  E. Pfefferkorn.  Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[67]  D. Sachs,et al.  Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts , 1984, Nature.

[68]  D. Wilson,et al.  Histocompatibility antigen-activated cytotoxic T lymphocytes. I. Estimates of the absolute frequency of killer cells generated in vitro , 1977, The Journal of experimental medicine.

[69]  W. Weimar,et al.  FOXP3 mRNA expression analysis in the peripheral blood and allograft of heart transplant patients. , 2008, Transplant immunology.

[70]  O. Joffre,et al.  Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes , 2008, Nature Medicine.

[71]  K. Wood,et al.  The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation. , 2005, Transplantation proceedings.

[72]  D. Keskin,et al.  Tryptophan catabolism and T cell responses. , 2003, Advances in experimental medicine and biology.

[73]  K. Wood,et al.  Regulatory lymphocytes: Regulatory T cells in transplantation tolerance , 2003, Nature Reviews Immunology.

[74]  T. Strom,et al.  IL-15 and IL-2: a matter of life and death for T cells in vivo , 2001, Nature Medicine.

[75]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.

[76]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[77]  W. Born,et al.  Immunoregulatory functions of gamma delta T cells. , 1999, Advances in immunology.

[78]  H. Waldmann,et al.  Brief Definitive Report Identification of Regulatory T Cells in Tolerated Allografts , 2022 .